Market Cap (In CNY)
21.96 Billion
Revenue (In CNY)
8.54 Billion
Net Income (In CNY)
1.07 Billion
Avg. Volume
15.23 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 12.24-17.77
- PE
- -
- EPS
- -
- Beta Value
- 0.444
- ISIN
- CNE000001C81
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Jing Su
- Employee Count
- -
- Website
- https://www.tasly.com
- Ipo Date
- 2002-08-23
- Details
- Tasly Pharmaceutical Group Co., Ltd. engages in biological medicine, health, and medical service businesses in China. It offers herbal and chemical medicines, health products, pharmaceutical substances and APIs, herbal extracts, concentrated herbal granules, and tea series products. The company also provides cosmetic series products, including moisture lotions, moisture creams, eye creams, and face washing foams; daily hygiene products, such as sanitary and carefree pads, honey-propolis soaps, and pollen soaps; and medical equipment, which include massage tappers, massage cushions, and circulation machines. It also exports its products to the United States, Russia, and countries in Europe, Africa, and rest of Asia. Tasly Pharmaceutical Group Co., Ltd. was founded in 1994 and is based in Tianjin, China.
More Stocks
-
SHELShell plc
SHEL
-
603158
-
600398Hla Group Corp., Ltd.
600398
-
WWT
-
SBUX
-
0OJJACTIA Group S.A.
0OJJ
-
ATUSAltice USA, Inc.
ATUS
-
001525Tongyang Inc.
001525